• PK/PD Analysis of Gamithromycin Against P. multocida in Mice

  2026-07-27

  This study defines the pharmacokinetic/pharmacodynamic (PK/PD) profile of Gamithromycin for Pasteurella multocida lung infections using a murine model. By quantifying the relationship between drug exposure and antibacterial efficacy, the research provides a foundation for optimized dosing strategies in veterinary contexts.

• Sodium Dicloxacillin Monohydrate in MSSA Infection Research

  2026-07-26

  Harness sodium dicloxacillin monohydrate for robust, reproducible MSSA infection models that dissect intra- and extracellular antibiotic efficacy. This guide distills advanced workflows, troubleshooting strategies, and pivotal PK/PD insights to elevate your Gram-positive bacterial infection research.

• Cefepime (BMY-28142): Next-Gen Strategies for CNS Infection

  2026-07-25

  This article delivers advanced guidance for translational researchers modeling central nervous system (CNS) infections and antimicrobial resistance, leveraging the mechanistic and strategic strengths of Cefepime (BMY-28142). By integrating biological rationale, current PK/PD resistance research, and actionable protocol parameters, it positions APExBIO's Cefepime as a cornerstone for experimental innovation.

• Cefepime (BMY-28142): Optimizing CNS Infection Research Work

  2026-07-24

  Cefepime (BMY-28142) combines robust blood-brain barrier penetration with broad-spectrum activity, making it a gold standard for central nervous system infection models and resistance studies. This guide delivers practical protocols, advanced use-cases, and troubleshooting strategies, leveraging the latest reference innovations and APExBIO’s trusted quality.

• LL-37 Peptide Fragments Suppress MDR Acinetobacter baumannii

  2026-07-24

  This study demonstrates that the human antimicrobial peptide LL-37 and its synthetic fragments exhibit both antimicrobial and antibiofilm effects against multidrug-resistant (MDR) Acinetobacter baumannii. The findings offer mechanistic insight into innate peptide-based strategies for overcoming biofilm-associated antibiotic resistance in difficult-to-treat Gram-negative infections.

• Sisomicin: Pharmacological Insights and Advanced Application

  2026-07-23

  Discover the unique pharmacology and research applications of Sisomicin, a powerful aminoglycoside antibiotic. This article delivers a deeper analysis of its antibacterial spectrum, pharmacokinetics, and practical assay decision-making for infection modelers.

• Optimizing Bicinchoninic Acid Protein Quantification in BBB

  2026-07-23

  The BCA Protein Assay Kit empowers precise protein quantification even from challenging, low-volume samples such as brain endothelial cell lysates. This article details its workflow, troubleshooting, and unique advantages in mechanistic studies of blood–brain barrier injury, leveraging insights from cutting-edge pyroptosis research.

• HyperScript III RT SuperMix: Precision RNA-to-cDNA for qPCR

  2026-07-22

  HyperScript III RT SuperMix delivers exceptional cDNA synthesis efficiency and robust genomic DNA removal, streamlining gene expression analysis even for low-copy and high-GC RNA targets. Its workflow enables reliable detection of critical biomarkers like CLCA1, UGT2A3, and ZG16, empowering advanced colorectal cancer subtyping and immune profiling.

• Differential BIRC2/3 Regulation by Cytokines and Glucocortic

  2026-07-22

  This study delineates how inflammatory cytokines and glucocorticoids differentially regulate the expression of BIRC2 and BIRC3 in pulmonary epithelial cells, clarifying their distinct roles in cell signaling and apoptosis. The findings have important implications for understanding epithelial responses to inflammation and steroid therapy, providing a foundation for further mechanistic and pharmacological research.

• Adamtsl3 Regulates PNN Integrity via MMP9 in Cortical Plasti

  2026-07-21

  The reference study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal net (PNN) formation and maintenance in parvalbumin-positive interneurons. By demonstrating Adamtsl3’s control over MMP9-mediated extracellular matrix remodeling, the research clarifies molecular links between PNN disruption and schizophrenia and highlights potential intervention strategies for neurodevelopmental disorder models.

• Tropisetron Hydrochloride: Precision in 5-HT3 Receptor Antag

  2026-07-21

  Tropisetron Hydrochloride empowers researchers with dual 5-HT3/α7-nicotinic modulation and robust, reproducible performance in neuroscience and renal transporter assays. Unlock advanced troubleshooting strategies and workflow enhancements with APExBIO’s high-purity compound for translational receptor signaling research.

• Hexetidine (NSC-17764): Translational Insights for Oral Infe

  2026-07-20

  This thought-leadership article bridges molecular mechanisms, experimental protocols, and translational strategy for deploying Hexetidine (NSC-17764) in oral infection research. Designed for translational scientists, it contextualizes recent evidence on biofilm disruption, competitive positioning versus chlorhexidine, and best practices for protocol integration, culminating in actionable future-facing guidance.

• DPPH Radical Assay: Applied Workflows for Antioxidant Screen

  2026-07-20

  Harness the DPPH (2,2-Diphenyl-1-Picrylhydrazyl) Radical for robust, reproducible in vitro antioxidant assays—even with complex natural extracts. This guide delivers stepwise workflow enhancements, troubleshooting strategies, and insights from comparative studies, ensuring maximum assay performance for high-throughput antioxidant screening and natural product evaluation.

• Methicillin Sodium Salt: Optimizing Infection Models & Assay

  2026-07-19

  Methicillin sodium salt remains the benchmark compound for modeling Staphylococcus aureus susceptibility and resistance in translational research. This guide details robust experimental workflows, data-driven parameterization, and troubleshooting strategies to maximize the reliability and interpretability of your bacterial cell wall synthesis assays.

• Standardized Amplex Red Assay for Autotaxin Inhibitor Screen

  2026-07-18

  Stylianaki et al. present a rigorously validated, fluorescence-based microplate protocol using Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) to quantify the efficacy and kinetics of autotaxin (ATX) inhibitors. This standardized workflow enables high-throughput, reproducible assessment of candidate compounds and provides a robust platform for drug discovery targeting ATX-mediated pathologies.

466 records 11/32 page Previous Next First page 上5页 1112131415 下5页 Last page